Statistics
Publications
17
Citations
849
H-Index
16
Active since
2011
Xuan Luo is an author at Affiliated Hospital of Jiangsu University specializing in medicine, oncology, and autoimmunity.
Publications per year
2011–2024
17
17
TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
Wenliang Tan, Xuan Luo, Wenda Li et al. · EBioMedicine · 2018 · 109 citations · Full text
Medicine, Oncology, Pharmacology +16
Oncogenic miR-9 is a target of erlotinib in NSCLCs
Xi Chen, Lingjun Zhu, Zhuo Ma et al. · Scientific Reports · 2015 · 60 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 17